Travoprost Ophthalmic Solution — FDA Drug Shortage
The FDA lists a drug shortage record for Travoprost Ophthalmic Solution (ophthalmic solution) from Mylan Pharmaceuticals Inc., A Viatris Company with status To Be Discontinued. The shortage was first posted on Jul 7, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Mylan Pharmaceuticals Inc., A Viatris Company
- Package NDC
- 0378-9651-50
- Dosage Form
- Ophthalmic Solution
- Presentation
- Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50)
- Initial Posting
- Jul 7, 2026